UNII 3SY5LH9PMK

ANHYDROUS LACTOSE

Unique Ingredient Identifier 3SY5LH9PMK is listed as a ingredient substance
RN63-42-3
EC200-559-2
NCITC74579
RXCUI1307662

Alternate Names

Dosage Forms

UNII 3SY5LH9PMK ANHYDROUS LACTOSE is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALTABLET23.75 MG
IM - IVINJECTABLE2.5 %
IM - IVPOWDER, FOR INJECTION SOLUTION2.5 %
INHALATIONPOWDER1.16 MG/1INH
INTRACAVITARYPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED4.75 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED5.7 %W/V
IV(INFUSION)POWDER, FOR INJECTION SOLUTION2.5 %
ORALCAPSULE402.5 MG
ORALCAPSULE (IMMED./COMP. RELEASE)46.06 MG
ORALCAPSULE, COATED, SOFT GELATIN71.91 MG
ORALCAPSULE, DELAYED RELEASE40 MG
ORALCAPSULE, ENTERIC COATED PELLETS117 MG
ORALCAPSULE, EXTENDED RELEASE53.8 MG
ORALCAPSULE, HARD GELATIN238.24 MG
ORALCAPSULE, SUSTAINED ACTION300.8 MG
ORALGRANULE433 MG
ORALGRANULE, FOR RECONSTITUTION15.69 MG
ORALPOWDER, FOR ORAL SUSPENSION468.7 MG/5ML
ORALTABLET735.2 MG
ORALTABLET (IMMED./COMP. RELEASE), COATED93.3 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED204 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL98.7 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE108 MG
ORALTABLET, CHEWABLE475.5 MG
ORALTABLET, COATED144.19 MG
ORALTABLET, DELAYED ACTION333 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED90 MG
ORALTABLET, DELAYED RELEASE420 MG
ORALTABLET, EXTENDED RELEASE264.45 MG
ORALTABLET, FILM COATED453.6 MG
ORALTABLET, FILM COATED, EXTENDED RELEASE48 MG
ORALTABLET, ORALLY DISINTEGRATING25 MG
ORALTABLET, SUSTAINED ACTION180.9 MG
ORALTABLET, SUSTAINED ACTION, COATED130.7 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED157.95 MG
SUBLINGUALTABLET128 MG
VAGINALTABLET605 MG

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.